Gary Jacobson Named Executive Vice President and Chief Financial Officer at Ricerca...
* Reuters is not responsible for the content in this press release.
Gary Jacobson Named Executive Vice President and Chief Financial Officer at Ricerca Biosciences CONCORD, Ohio--(Business Wire)-- Ricerca Biosciences, a uniquely integrated preclinical provider of contract research services for the pharmaceutical industry has named Gary Jacobson executive vice president and chief financial officer. In addition to his financial responsibilities, he will be accountable for Ricerca's legal, human resources, facilities and IT functions. "I'm delighted to welcome Gary to Ricerca," said Ricerca Chairman & CEO, R. Ian Lennox. "Gary will further strengthen Ricerca's management team and provide valuable capabilities for our continued successful growth." Prior to joining Ricerca, Jacobson was principal and director of General Biotechnology, LLC. He served as executive vice president and chief financial officer of Harlan Sprague Dawley, Inc. and chief operating officer of Harlan Europe. Gary began his career in the banking industry serving as senior vice president and division manager of LaSalle National Bank and senior vice president of American National Bank. Jacobson is a graduate of Knox College in Galesburg, IL, and holds a certificate in political economy from the Adam Smith School of Economics in Glasgow, Scotland. He received his MBA from Marshall University in Huntington, WV. About Ricerca Biosciences Ricerca is the only North American CRO that takes pharmaceutical and biotech companies straight through from IP to IND. Our state-of-the-art facility combined with over 300 scientists and support staff provides all of the discovery and development services required to bring target or drug candidates to complete IND submission. Ricerca's unique ability to seamlessly integrate chemistry and biology, along with report writing and regulatory services at one location, allows companies to achieve their preclinical destination--faster and without any detours. Ricerca Biosciences Wendy Rich, 440-357-3607 Rich_w@ricerca.com Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters